July 13, 2023 C-Path and Vivpro Formalize Partnership to Accelerate Drug Development The strategic collaboration between C-Path and Vivpro seeks to leverage Vivpro’s innovative biointelligence platform, foster
July 12, 2023 Sanford Health Rare Disease Data Registry Partners with C-Path’s RDCA-DAP, Cure Mito Foundation to Aggregate Rare Disease Data in Platform TUCSON, Ariz., July 12, 2023 — Critical Path Institute (C-Path) announced today that the Coordination of Rare Diseases based at
July 6, 2023 Multistakeholder Collaborations Are Vital to Advancing Technologies in Parkinson’s TUCSON, Ariz., July 6, 2023 — Critical Path Institute (C-Path) and the Center for Health + Technology (CHeT) at University of Ro
June 28, 2023 C-Path’s TRxA Announces $750,000 in Research Awards to Accelerate its First Drug Development Projects TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda
June 20, 2023 C-Path’s Integrated Clinical Trial Database to Help Advance Research in Parkinson’s TUCSON, Ariz., June 20, 2023 — Critical Path Institute (C-Path), an independent nonprofit organization, today announced it is pr
June 13, 2023 C-Path’s PSTC Receives Positive FDA Response for Drug-Induced Pancreatic Injury Biomarkers Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical
June 8, 2023 C-Path and I-ACT Collaborate on EHR Data Transfer A Major Milestone for Pediatric Real-World Data Project TUCSON, Ariz., June 8, 2023 — Critical Path Institute‘s (C-Path) I
June 7, 2023 Newcastle University’s John Walton Muscular Dystrophy Research Centre Contributes Data to C-Path’s RDCA-DAP TUCSON, Ariz., June 7, 2023 — Critical Path Institute (C-Path) announced today that Newcastle University UK’s John Walton Musc
June 7, 2023 Shaping the Global Innovation and Access Landscape for Better Paediatric Medicines: C-Path Becomes Official Partner of WHO TUCSON, Ariz. and AMSTERDAM, June 7, 2023 — Critical Path Institute (C-Path), a leading global nonprofit committed to expediting
May 31, 2023 CACNA1A Foundation to Contribute Data to C-Path’s RDCA-DAP, Accelerating Neurological Disease Research and Therapeutic Development TUCSON, Ariz., May 31, 2023 — Critical Path Institute (C-Path) announced today that the CACNA1A Foundation, a parent-led nonprof
